from Reuters: U.S. https://ift.tt/2ItvspY
Catalyst Pharmaceuticals defends $375,000 drug price after Bernie Sanders rebuke
Catalyst Pharmaceuticals Inc, rebuked by U.S. Senator Bernie Sanders for its high drug prices, on Thursday defended its $375,000 treatment for a rare disease, saying the price was in line with similar products in the industry.
from Reuters: U.S. https://ift.tt/2ItvspY
from Reuters: U.S. https://ift.tt/2ItvspY
0 comments:
Post a Comment